Now showing items 1-1 of 1

    • Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas 

      Guil-Luna, Silvia; Sánchez Céspedes, Raquel; Millán, Yolanda; De Andrés, Francisco Javier; Rollón, Eva; Domingo, Victor; Guscetti, Franco; Martín de las Mulas González-Albo, Juana (Wiley, 2011)
      Progesterone receptor (PR) antagonist aglepristone (RU534) has been used successfully for pregnancy termination and therapy of pyometra, vaginal tumors, and mammary hyperplasia in bitches and queens. All of these conditions ...